<DOC>
	<DOCNO>NCT00753506</DOCNO>
	<brief_summary>The investigator intend explore hypothesis symptom schizophrenia may reduce antimalarial compound artemisinin use addition standard antipsychotic medication .</brief_summary>
	<brief_title>Artemisinin Reduce The Symptoms Schizophrenia</brief_title>
	<detailed_description>The aim current study : 1 . To evaluate efficacy side effect artemisinin add-on compound patient schizophrenia residual psychotic symptom least moderate severity . 2 . To evaluate effect artemisinin cognitive impairment associate functional skill . 3 . To investigate whether treatment artemisinin produce significant effect level antibody Toxoplasma . 4 . To examine whether change cognitive impairment psychiatric symptom correlate change antibody Toxoplasma treatment artemisinin .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemisinine</mesh_term>
	<criteria>Inclusion Criteria Age 1865 year old . Capacity write informed consent . Primary Axis I diagnosis ( DSMIV ) schizophrenia , type , OR schizoaffective disorder ( APA , 1994 ) . Currently outpatient time enrollment . Residual psychotic symptom least moderately severe evidence one Positive Negative Syndrome Scale ( PANSS ) positive symptom score , and/or PANSS negative symptom score 4 ; OR total PANSS score 50 , contain least three positive negative item score 3 screening . Conformance Patient Outcome Research Team ( PORT ) Treatment Recommendation # 5 , Maintenance Antipsychotic Medication Dose ( Lehman et al. , 2004 ) . Receiving antipsychotic medication least 8 week prior start study medication change within previous 21 day . Participants must proficient English . Exclusion Criteria Diagnosis mental retardation . History IV drug use . Any serious medical condition affect brain cognitive functioning ( e.g. , epilepsy , serious head injury , brain tumor neurological disorder ) . HIV infection immunodeficiency condition . Primary diagnosis substance abuse dependence accord DSMIV criterion within last three month . Participated investigational drug trial past 30 day . Pregnancy plan become pregnant study period . Any clinically significant unstable medical disorder determine investigator would preclude study participation , include congestive heart failure , abnormal liver function disease , renal failure , diagnosis cancer undergo active treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>